Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer ?-amyloid deposition
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, because A is a constituent of the interstitial fluid flowing along perivascular cells toward the cerebrospinal fluid and because A in CAA is initially deposited in the adventitia, 44 it is very possible that perivascular cells (ie, pericytes and smooth muscle cells) contribute to the process of transport of A from brain to blood as well.”
From Lipoprotein Receptor-Related Protein-1 Mediates Amyloid-β-Mediated Cell Death of Cerebrovascular Cells (2007) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731 · cited 1×
“cultured cells [3, 8, 28], and soluble A13 is present in the cerebrospinal fluid [26, 28].”
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447 · cited 1×
“cultured cells [3, 8, 28], and soluble A13 is present in the cerebrospinal fluid [26, 28].”
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363 · cited 1×
“ApoE binds to A13 and forms a stable complex [31, 35].”
Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)91092-f · Cited by 1,157 · cited 5×
“ApoE is considered to be one such factor for the following reasons: ApoE immunoreactivity has been found on senile plaques [11, 15, 20, 30, 34] and has been demonstrated on amyloid fibrils in an immune electron microscopic”
InfluentialApolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
William Rebeck, G., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) · Neuron · doi:10.1016/0896-6273(93)90070-8 · Cited by 1,107 · cited 4×
“ApoE is considered to be one such factor for the following reasons: ApoE immunoreactivity has been found on senile plaques [11, 15, 20, 30, 34] and has been demonstrated on amyloid fibrils in an immune electron microscopic”
InfluentialApolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802 · cited 4×
“Although intraneuronal NFT in cryostat sections were positive for ApoE [15], ApoE immunoreactivity has been found only on the extracellular NFT in paraffin-embedded tissue sections ([15, 34] and the present study).”
InfluentialRoher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zürcher-Neely, H. A., Heinrikson, R. L., & Ball, M. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53661-9 · Cited by 799
Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells.
Busciglio, J., Gabuzda, D. H., Matsudaira, P., & Yankner, B. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2092 · Cited by 569 · cited 2×
“cultured cells [3, 8, 28], and soluble A13 is present in the cerebrospinal fluid [26, 28].”
The occult aftermath of boxing.
Roberts, G. W., Allsop, D., & Bruton, C. (1990) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.5.373 · Cited by 518 · cited 1×
“, Alzheimer's disease, Down's syndrome [14] and dementia pugilistica [21].”
Research works printed but not linked: 31
- Abraham CR, Selkoe DJ, Potter H (1988) Immunochemical identification of the serine protease inhibitor ?1-in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487?501 · DOI · Paper page
- Allsop D, Haga S, Bruton C, Ishii T, Roberts GW (1990) Neurofibrillary tangles in some cases of dementia pugilistica share antigens with amyloid ?-protein of Alzheimer's disease. Am J Pathol 136: 255?260
- Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921?923 · DOI · Paper page
- Diedrich JF, Minnigan H, Carp RI, Whitaker JN, Race R, Frey H, Haase AT (1991) Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65: 4759?4768 · DOI · Paper page
- Goedert M (1987) Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease. EMBO J 6: 3627?3632 · DOI · Paper page
- Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG (1990) Expression of ? amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron 4: 253?267 · DOI · Paper page
- Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K, Müller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733?736 · DOI · Paper page
- Kawarabayashi T, Shoji M, Harigaya Y, Yamaguchi H, Hirai S (1991) Amyloid ?/A4 protein precursor is widely distributed in both the central and peripheral nervous systems of the mouse. Brain Res 552: 1?7 · DOI
- Kida E, Golabek AA, Wisniewski T, Wisniewski KE (1994) Regional difference in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain. Neurosci Lett 167: 73?76 · DOI
- Koo EH, Abraham CR, Potter H, Cork LC, Price DL (1991) Developmental expression of ? 1-antichymotrypsin in brain may be related to astrogliosis. Neurobiol Aging 12: 495?501 · DOI
- Majack RA, Castle CK, Goodman LV, Weisgraber KH, Mahley RW, Shooter EM, Gebicke-Hearter PJ (1988) Expression of apolipoprotein E by cultured vascular smooth muscle cells is controled by growth state. J Cell Biol 107: 1207?1213 · DOI · Paper page
- Neve RL, Finch EA, Dawes LR (1988) Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron 1: 669?677 · DOI · Paper page
- Pasternack JM, Abraham CR, Van Dyke B, Potter H, Younkin SG (1989) Astrocytes in Alzheimer's disease gray matter express ?-1-antichymotrypsin mRNA. Am J Pathol 135: 827?834
- Perry G, Cras P, Siedlak SL, Tabaton M, Kawai M (1992) ?Protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am J Pathol 140: 283?290
- Perry G, Richey PL, Siedlak SL, Smith MA, Mulvihill P, DeWitt DA, Barnett J, Greenberg BD, Kalaria RN (1993) Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Am J Pathol 143: 1586?1593
- Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele ? 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467?1472 · DOI · Paper page
- Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, Goldfarb L, Goldgaber D, Manwaring MG, Szymanski MH, McCown N, Dole KC, Schmechel DE, Strittmatter WJ, Pericak-Vance MA, Roses AD (1993) Apolipoprotein E ? 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342: 710?711 · DOI · Paper page
- Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid ?-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90: 9649?9653 · DOI · Paper page
- Shoji M, Hirai S, Yamaguchi H, Harigaya Y, Ishiguro K, Matsubara E (1991) ?1-antichymotrypsin is present in diffuse senile plaques: a comparative study of both ? protein and ?1-antichymotrypsin immunostaining in the Alzheimer brains. Am J Pathol 138: 247?257
- Spillantini MG, Goedert M, Jakes R, Klug A (1990) Topographical relationship between ? amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer disease. Proc Natl Acad Sci USA 87: 3952?3956 · DOI · Paper page
- Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to ?-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl. Acad Sci USA 90: 1977?1981 · DOI · Paper page
- Sugihara S, Ogawa A, Nakazato Y, Yamaguchi H (1994) Cerebral ? amyloid deposition in the patients with malignant neoplasm: its incidence with aging and effect of radiation therapy on vascular amyloid. Acta Neuropathol (in press) · DOI
- Tabaton M, Cammarata S, Manetto V, Autilio-Gambetti L, Perry G, Gambetti P (1991) Ultrastructural localization of ?-amyloid, ?, and ubiquitin epitopes in extracellular neurofibrillary tangles. Proc Natl Acad Sci USA 88: 2098?2102 · DOI · Paper page
- Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B (1993) Apolipoprotein E: binding to soluble Alzheimer's ?-amyloid. Biochem Biophys Res Commun 192: 359?365 · DOI · Paper page
- Yamaguchi H, Morimatsu H, Hirai S, Takahashi K (1987) Alzheimer's neurofibrillary tangles are penetrated by astroglial processes and appear eosinophilic in their final stages. Acta Neuropathol (Berl) 72: 214?217 · DOI
- Yamaguchi H, Hirai S, Morimatsu M, Shooji M, Ihara Y (1988) A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by ? protein immunostaining. Acta Neuropathol 76: 541?549 · DOI · Paper page
- Yamaguchi H, Ishiguro K, Shoji M, Yamazaki T, Ihara Y, Hirai S (1990) Amyloid ? protein precursor is bound to neurofibrillary tangles in Alzheimer-type dementia. Brain Res 537: 318?328 · DOI
- Yamaguchi H, Nakazato Y, Shoji M, Okamoto K, Ihara Y, Morimatsu M, Hirai S (1991) Secondary deposition of ? amyloid within extracellular neurofibrillary tangles in Alzheimer-type dementia. Am J Pathol 138: 699?705
- Yamaguchi H, Nakazato Y, Shoji M, Takatama M, Hirai S (1991) Ultrastructure of the diffuse plaques in the senile dementia of the Alzheimer type: comparison with the primitive plaques. Acta Neuropathol 82: 13?20 · DOI
- Yamaguchi H, Nakazato Y, Yamazaki T, Shoji M, Kawarabayashi T, Hirai S (1991) Subpial ?/A4 amyloid deposition occurs between astroglial processes in Alzheimer-type dementia. Neurosci Lett 223: 217?220 · DOI
- Yamaguchi H, Yamazaki T, Lemere CA, Frosch MP, Selkoe DJ (1992) Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease: an immunoelectron microscopic study. Am J Pathol 141: 249?259
Cited by
Cerebral vessels in ageing and Alzheimer's disease
Kalaria, R. N. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00116-7 · Cited by 336
Overlap between neurodegenerative disorders
Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2005.00605.x · Cited by 146
Wilhelmus, M. M. M., Otte-Höller, I., van Triel, J. J. J., Veerhuis, R., Maat-Schieman, M. L. C., Bu, G., de Waal, R. M. W., & Verbeek, M. M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070050 · Cited by 138
Shinkai, Y., Yoshimura, M., Ito, Y., Odaka, A., Suzuki, N., Yanagisawa, K., & Ihara, Y. (1995) · Annals of Neurology · doi:10.1002/ana.410380312 · Cited by 127
Shinohara, M., Fujioka, S., Murray, M. E., Wojtas, A., Baker, M., Rovelet-Lecrux, A., Rademakers, R., Das, P., Parisi, J. E., Graff-Radford, N. R., et al. (2014) · Brain · doi:10.1093/brain/awu046 · Cited by 115
“…amyloid plaques, apoE has been shown to co-deposit with extracellular neurofibrillary tangles, Pick bodies, and prion plaques (Namba et al., 1991; Yamaguchi et al., 1994; Hayashi et al., 1998; Nakamura et al., 2000), which suggests that apoE has a strong affinity to amyloid aggregates in…”
A critical analysis of the ‘amyloid cascade hypothesis’
A. Armstrong, R. (2014) · Folia Neuropathologica · doi:10.5114/fn.2014.45562 · Cited by 110
Thal, D. R., Arendt, T., Waldmann, G., Holzer, M., Zedlick, D., Rüb, U., & Schober, R. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00090-6 · Cited by 53
Thal, D. R., Capetillo-Zarate, E., Schultz, C., Rüb, U., Saido, T. C., Yamaguchi, H., Haass, C., Griffin, W. S. T., Del Tredici, K., Braak, H., et al. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1053-1 · Cited by 50
“Note that extracellular neurofibrillary tangles are marked with the antibody against apoE (N, arrowheads) [51].”
BackgroundSelf-citationApolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls
Pirttilä, T., Soininen, H., Heinonen, O., Lehtimäki, T., Bogdanovic, N., Paljärvi, L., Kosunen, O., Winblad, B., Riekkinen, P., Wisniewski, H. M., et al. (1996) · Brain Research · doi:10.1016/0006-8993(96)00183-7 · Cited by 42
Metadata
- Authors
- Yamaguchi, H., Ishiguro, K., Sugihara, S., Nakazato, Y., Kawarabayashi, T., Sun, X., & Hirai, S.
- Venue
- Acta Neuropathologica
- Published
- 1994
- Volume
- 88
- Issue
- 5
- Pages
- 413-419
- ISSN
- 0001-6322
- 1432-0533
- Cited by
- 51
- References
- 11
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.